• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.98% Nasdaq Up 1.39%

    Synergy Pharmaceuticals, Inc. (SGYP)

    -NasdaqGS
    6.95 Up 0.13(1.91%) 3:22PM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:6.82
    Open:6.89
    Bid:6.93 x 600
    Ask:6.94 x 1000
    1y Target Est:13.00
    Beta:-0.230694
    Next Earnings Date:N/A
    Day's Range:6.67 - 6.98
    52wk Range:2.45 - 10.15
    Volume:828,569
    Avg Vol (3m):5,958,570
    Market Cap:781.65M
    P/E (ttm):N/A
    EPS (ttm):-1.18
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    SGYPUp 1.91%781.65M
    IRWDDown 0.36%1.56B
    SLXP 0.00%10.88B
    SCMPUp 5.93%1.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.16
    Quarterly EPS Est (Sep-15) :-0.26
    Mean Recommendation*:1.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Synergy Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development of drugs to treat gastrointestinal (GI) disorders and diseases. Its lead product candidate is plecanatide, a guanylyl cyclase C receptor agonist that is in Phase... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback